Cointime

Download App
iOS & Android

Kala Pharmaceuticals

company
Funding Round
Post-IPO Equity
Money Raised
$ 31M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion

Historical Financing

Announced Date Round Money Raised Investors
Oct 3, 2018 Post-IPO Equity $ 110M Athyrium Capital Management LP Detail
Apr 13, 2016 Series C $ 68M CAM Capital,Longitude Capital,etc. Detail
Feb 28, 2013 Series A $ 11.50M Crown Venture Fund,Lux Capital,etc. Detail
Apr 23, 2014 Series B $ 22.50M AbbVie Biotech Ventures,Crown Venture Fund,etc. Detail
Dec 24, 2009 Series A $ 2M Detail
May 12, 2021 Post-IPO Debt $ 125M Oxford Finance LLC Detail
Mar 14, 2012 Private Equity(PE) $ 7.24M Lighthouse Capital Partners,Lux Capital,etc. Detail
Nov 10, 2010 Series Unknown $ 3M Detail
Apr 6, 2020 Post-IPO Equity $ 134M Detail
Nov 29, 2021 Post-IPO Equity $ 16.12M Detail
Aug 17, 2015 Series Unknown $ 6.99M Detail
Jul 20, 2017 IPO $ 90M Detail